{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:14:39Z","timestamp":1788545679363,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000104","name":"National Aeronautics and Space Administration","doi-asserted-by":"publisher","award":["#80NSSC19M0148"],"award-info":[{"award-number":["#80NSSC19M0148"]}],"id":[{"id":"10.13039\/100000104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005759","name":"Puerto Rico Space Grant Consortium","doi-asserted-by":"publisher","award":["#80NSSC20M0052"],"award-info":[{"award-number":["#80NSSC20M0052"]}],"id":[{"id":"10.13039\/100005759","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["#DMR-1827894"],"award-info":[{"award-number":["#DMR-1827894"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CHE-1626103"],"award-info":[{"award-number":["CHE-1626103"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["EPS-100241"],"award-info":[{"award-number":["EPS-100241"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-2425113"],"award-info":[{"award-number":["DMR-2425113"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s11095-026-04148-7","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:48:13Z","timestamp":1783626493000},"page":"2269-2281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enabling Personalized Dose Formulation by Evaporative Crystallization Process"],"prefix":"10.1007","volume":"43","author":[{"given":"Nicole M.","family":"Torres-Col\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesly","family":"Carmona-Sarabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliou","family":"Mbodji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indumathi","family":"Sathisaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe M.","family":"Monbaliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis P.","family":"Vlaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Duconge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo J.","family":"Roma\u00f1ach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3881-0183","authenticated-orcid":false,"given":"Torsten","family":"Stelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"4148_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.125070","volume":"670","author":"JE Mart\u00ednez-Jim\u00e9nez","year":"2025","unstructured":"Mart\u00ednez-Jim\u00e9nez JE, Sathisaran I, Reyes Figueroa F, Reyes S, L\u00f3pez-Nieves M, Vlaar CP, et al. A review of precision medicine in developing pharmaceutical products: perspectives and opportunities. Int J Pharm. 2025;670:125070.","journal-title":"Int J Pharm"},{"key":"4148_CR2","doi-asserted-by":"crossref","unstructured":"Yu, L X, Jiang W, Zhang X, Lionberger R, Makhlouf F, Schuirmann D J, Muldowney J, Chen M L, Davit B, Conner D, Woodcock J. Novel bioequivalence approach for narrow therapeutic index drugs. Clin Pharmacol Ther. 2015;97(3):286-91.","DOI":"10.1002\/cpt.28"},{"key":"4148_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125957","volume":"682","author":"S Wu","year":"2025","unstructured":"Wu S, Liu Y, Fan X, Shen Y, Qu H. Trends and new process analytical technologies in pharmaceutical manufacturing. Int J Pharm. 2025;682:125957.","journal-title":"Int J Pharm"},{"issue":"March","key":"4148_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2026.127044","volume":"700","author":"A Mbodji","year":"2026","unstructured":"Mbodji A, Arroyo A, Bigio G, Vlaar CP, Duconge J, Monbaliu JM, et al. Evaporative coupled with antisolvent crystallization for additive manufacturing of personalized solid dosage forms. Int J Pharm. 2026;700(March):127044.","journal-title":"Int J Pharm"},{"key":"4148_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejpb.2019.01.011","volume":"136","author":"S Niese","year":"2019","unstructured":"Niese S, Quodbach J. Formulation Development of a Continuously Manufactured Orodispersible Film Containing Warfarin Sodium for Individualized Dosing. Eur J Pharm Biopharm. 2019;136:93\u2013101.","journal-title":"Eur J Pharm Biopharm"},{"key":"4148_CR6","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ad3a14","author":"H Peng","year":"2024","unstructured":"Peng H, Han B, Tong T, Jin X, Peng Y, Guo M, et al. 3D printing processes in precise drug delivery for personalized medicine. Biofabrication. 2024. https:\/\/doi.org\/10.1088\/1758-5090\/ad3a14.","journal-title":"Biofabrication"},{"key":"4148_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309164","author":"P Carou-Senra","year":"2024","unstructured":"Carou-Senra P, Rodr\u00edguez-Pombo L, Awad A, Basit AW, Alvarez-Lorenzo C, Goyanes A. Inkjet printing of pharmaceuticals. Adv Mater. 2024. https:\/\/doi.org\/10.1002\/adma.202309164.","journal-title":"Adv Mater"},{"issue":"September","key":"4148_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126197","volume":"685","author":"A Mbodji","year":"2025","unstructured":"Mbodji A, Cruz KM, G\u00f3mez AA, Vlaar CP, Duconge J, Monbaliu J-C, et al. Controlled API crystallization during additive manufacturing of solid dosage form for flexible integrated pharmaceutical manufacturing. Int J Pharm. 2025;685(September):126197.","journal-title":"Int J Pharm"},{"key":"4148_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125251","volume":"671","author":"X Rodr\u00edguez-Maci\u00f1eiras","year":"2025","unstructured":"Rodr\u00edguez-Maci\u00f1eiras X, Bendicho-Lavilla C, Rial C, Garba-Mohammed K, Worsley A, D\u00edaz-Torres E, et al. Advancing medication compounding: use of a pharmaceutical 3D printer to auto-fill minoxidil capsules for dispensing to patients in a community pharmacy. Int J Pharm. 2025;671:125251.","journal-title":"Int J Pharm"},{"issue":"7","key":"4148_CR10","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1021\/acs.molpharmaceut.4c00032","volume":"21","author":"TP Forbes","year":"2024","unstructured":"Forbes TP, Gillen JG, Feeney W, Ho J. Quality by design considerations for drop-on-demand point-of-care pharmaceutical manufacturing of precision medicine. Mol Pharm. 2024;21(7):3268\u201380.","journal-title":"Mol Pharm"},{"issue":"8","key":"4148_CR11","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1016\/j.xphs.2022.03.009","volume":"111","author":"V Sundarkumar","year":"2022","unstructured":"Sundarkumar V, Nagy ZK, Reklaitis GV. Small-scale continuous drug product manufacturing using dropwise additive manufacturing and three phase settling for integration with upstream drug substance production. J Pharm Sci. 2022;111(8):2330\u201340.","journal-title":"J Pharm Sci"},{"issue":"4","key":"4148_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph15040435","volume":"15","author":"AM Malebari","year":"2022","unstructured":"Malebari AM, Kara A, Khayyat AN, Mohammad KA, Serrano DR. Development of advanced 3D-printed solid dosage pediatric formulations for HIV treatment. Pharmaceuticals (Basel). 2022;15(4):1\u201315.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"4148_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-018-1224-8","volume":"20","author":"M \u0160oltys","year":"2019","unstructured":"\u0160oltys M, Akhlasov\u00e1 S, Zadra\u017eil A, Kova\u010d\u00edk P, \u0160t\u011bp\u00e1nek F. Manufacturing of multi-drug formulations with customised dose by solvent impregnation of mesoporous silica tablets. AAPS PharmSciTech. 2019;20(1):1\u201310.","journal-title":"AAPS PharmSciTech"},{"key":"4148_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122753","volume":"15","author":"S Jacob","year":"2023","unstructured":"Jacob S, Boddu SHS, Bhandare R, Ahmad SS, Nair AB. Orodispersible films\u202f: current innovations and emerging trends. Pharmaceutics. 2023;15:2753.","journal-title":"Pharmaceutics"},{"key":"4148_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11120633","volume":"11","author":"M Alhijjaj","year":"2019","unstructured":"Alhijjaj M, Nasereddin J, Belton P, Qi S. Impact of processing parameters on the quality of pharmaceutical solid dosage forms produced by fused deposition modeling (FDM). Pharmaceutics. 2019;11:633.","journal-title":"Pharmaceutics"},{"key":"4148_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/cryst13030527","volume":"13","author":"Z Petr","year":"2023","unstructured":"Petr Z, Drahozal M, R\u00f6merov S, Marinko N. Drug Release from Carrier Systems Comprising Meloxicam Crystals Formed by Impregnation-Evaporation. Crystals. 2023;13:527.","journal-title":"Crystals"},{"key":"4148_CR17","first-page":"533","volume":"57","author":"C Tourne","year":"2004","unstructured":"Tourne C, Nicole L, Lerner DA, Devoisselle JM, Charnay C, Be S. Inclusion of ibuprofen in mesoporous templated silica\u202f: drug loading and release property. 2004;57:533\u201340.","journal-title":"Inclusion of ibuprofen in mesoporous templated silica : drug loading and release property"},{"key":"4148_CR18","doi-asserted-by":"crossref","unstructured":"Leia Dwyer, Samir Kulkarni LR and AM. Two-Stage crystallizer design for high loading of poorly water-soluble pharmaceuticals in porous. Crystals. 2017;7:131.","DOI":"10.3390\/cryst7050131"},{"key":"4148_CR19","doi-asserted-by":"crossref","unstructured":"Grigorov PI, Glasser BJ, Muzzio FJ. Formulation and manufacture of pharmaceuticals by fluidized-bed impregnation of active pharmaceutical ingredients onto porous carriers. AIChE J. 2013;59:4538\u201352.","DOI":"10.1002\/aic.14209"},{"key":"4148_CR20","doi-asserted-by":"crossref","unstructured":"Forbes TP, Agolini, Olivia, Zainab Altamimi JL. Pharmaceutics approach to printable tablet production \u2020. RSC Pharm. 2025;2:1096\u2013109.","DOI":"10.1039\/D5PM00041F"},{"key":"4148_CR21","unstructured":"Goel N. Suspensions-I. In: E-ISBN:978\u201393\u20136252\u2013980\u20130, editor. Edited Book of Pharmaceutics \u2013 I. Satna: Iterative International Publishers (IIP); 2024. p. 142\u2013150."},{"issue":"5\u20136","key":"4148_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.drudis.2007.11.006","volume":"13","author":"A Llin\u00e0s","year":"2008","unstructured":"Llin\u00e0s A, Goodman JM. Polymorph control: past, present and future. Drug Discov Today. 2008;13(5\u20136):198\u2013210.","journal-title":"Drug Discov Today"},{"issue":"4","key":"4148_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","volume":"16","author":"LX Yu","year":"2014","unstructured":"Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771\u201383.","journal-title":"AAPS J"},{"issue":"2","key":"4148_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12247-015-9218-5","volume":"10","author":"L Hirshfield","year":"2015","unstructured":"Hirshfield L, I\u00e7ten E, Giridhar A, Nagy ZK, Reklaitis GV. Real-time process management strategy for dropwise additive manufacturing of pharmaceutical products. J Pharm Innov. 2015;10(2):140\u201355.","journal-title":"J Pharm Innov"},{"issue":"2017","key":"4148_CR25","first-page":"248","volume":"115","author":"G Kollamaram","year":"2017","unstructured":"Kollamaram G, Hopkins SC, Glowacki BA, Croker DM, Walker GM. Inkjet printing of paracetamol and indomethacin using electromagnetic technology: rheological compatibility and polymorphic selectivity. Eur J Pharm Sci. 2017;115(2017):248\u201357.","journal-title":"Eur J Pharm Sci"},{"key":"4148_CR26","unstructured":"Food and Drugs and Administration. Guidance for Industry: Quality Considerations for Continuous Manufacturing [Internet]. FDA. 2023 [cited 2026 Feb 25]. p. 1\u201324. Available from: https:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm."},{"issue":"April","key":"4148_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2026.127046","volume":"700","author":"C Jorgensen","year":"2026","unstructured":"Jorgensen C, Mbodji A, Borchardt-setter KA, Weichmann A, Jeffery J, Yu L, et al. Non-destructive pipeline for analysis of crystalline solid dispersions. Int J Pharm. 2026;700(April):127046.","journal-title":"Int J Pharm"},{"issue":"9","key":"4148_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2165\/00003088-200847090-00002","volume":"47","author":"S Stehle","year":"2008","unstructured":"Stehle S, Kirchheiner J, Lazar A, Fuhr U. Pharmacogenetics of oral anticoagulants: a basis for dose individualization. Clin Pharmacokinet. 2008;47(9):565\u201394.","journal-title":"Clin Pharmacokinet"},{"key":"4148_CR29","unstructured":"Organization WH. World Health Organization Model List of Essential Medicines [Internet]. WHO. 2023 [cited 2026 Feb 25]. Available from: https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/essential-medicines-lists."},{"key":"4148_CR30","unstructured":"Food and Drugs and Administration. Coumadin\u00ae tablets (warfarin sodium tablets, USP) crystalline; Coumadin\u00ae for injection (warfarin sodium for injection, USP) [Internet]. 2016. p. 1\u201339. Available from: https:\/\/www.fda.gov\/drugsatfda. Accessed 06-03-3025."},{"key":"4148_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ejps.2017.09.017","volume":"109","author":"I Luk\u00e1\u0161ov\u00e1","year":"2017","unstructured":"Luk\u00e1\u0161ov\u00e1 I, Musel\u00edk J, Franc A, Gon\u011bc R, Mika F, Vetch\u00fd D. Factor analysis in optimization of formulation of high content uniformity tablets containing low dose active substance. Eur J Pharm Sci. 2017;109:541\u20137.","journal-title":"Eur J Pharm Sci"},{"key":"4148_CR32","doi-asserted-by":"publisher","DOI":"10.1208\/ps030103","author":"D Gao","year":"2001","unstructured":"Gao D, Maurin MB. Physical chemical stability of warfarin sodium. AAPS PharmSci. 2001. https:\/\/doi.org\/10.1208\/ps030103.","journal-title":"AAPS PharmSci"},{"issue":"11","key":"4148_CR33","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1021\/acs.cgd.0c01003","volume":"20","author":"HS Shah","year":"2020","unstructured":"Shah HS, Chaturvedi K, Dave RH, Bates S, Haware RV, Morris KR. New insights on warfarin sodium 2-propanol solvate solid-state changes using a multivariate approach. Cryst Growth Des. 2020;20(11):7328\u201340.","journal-title":"Cryst Growth Des"},{"issue":"1","key":"4148_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(01)00097-7","volume":"48","author":"SR Vippagunta","year":"2001","unstructured":"Vippagunta SR, Brittain HG, Grant DJW. Crystalline solids. Adv Drug Deliv Rev. 2001;48(1):3\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"4148_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/B978-0-12-802447-8.00002-9","volume-title":"Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice: Second Edition","author":"GGZ Zhang","year":"2017","unstructured":"Zhang GGZ, Zhou D. Crystalline and amorphous solids. In: Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice: Second Edition. Elsevier Inc.; 2017. p. 23\u201357."},{"issue":"21","key":"4148_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26216631","volume":"26","author":"E Dimitrokalli","year":"2021","unstructured":"Dimitrokalli E, Fertaki S, Lykouras M, Kokkinos P, Orkoula M, Kontoyannis C. Warfarin sodium stability in oral formulations. Molecules. 2021;26(21):6631.","journal-title":"Molecules"},{"key":"4148_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-chembioeng-061010-114224","volume":"2","author":"AY Lee","year":"2011","unstructured":"Lee AY, Erdemir D, Myerson AS. Crystal polymorphism in chemical process development. Annu Rev Chem Biomol Eng. 2011;2:259\u201380.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"4148_CR38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.4c00320","author":"DL Reid","year":"2025","unstructured":"Reid DL, Faul MM, L\u00f3pez-Mej\u00edas V, Agarwal P, Bergauer M, Blue LE, et al. Application of an interdisciplinary approach to form selection in drug development. Org Process Res Dev. 2025. https:\/\/doi.org\/10.1021\/acs.oprd.4c00320.","journal-title":"Org Process Res Dev"},{"issue":"18","key":"4148_CR39","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.1021\/cr500013u","volume":"115","author":"MA Czarnecki","year":"2015","unstructured":"Czarnecki MA, Morisawa Y, Futami Y, Ozaki Y. Advances in molecular structure and interaction studies using near-infrared spectroscopy. Chem Rev. 2015;115(18):9707\u201344.","journal-title":"Chem Rev"},{"key":"4148_CR40","unstructured":"Food & Drug Administraion. Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation. 2013;(March):5."},{"issue":"December 2023","key":"4148_CR41","first-page":"1","volume":"170","author":"K Rodr\u00edguez-Fern\u00e1ndez","year":"2024","unstructured":"Rodr\u00edguez-Fern\u00e1ndez K, Reynaldo-Fern\u00e1ndez G, Reyes-Gonz\u00e1lez S, de las Barreras C, Rodr\u00edguez-Vera L, Vlaar C, et al. New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK\/PD model. Biomed Pharmacother. 2024;170(December 2023):1\u20138.","journal-title":"Biomed Pharmacother"},{"key":"4148_CR42","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2020-0135","author":"S Reyes-Gonz\u00e1lez","year":"2020","unstructured":"Reyes-Gonz\u00e1lez S, De Las Barreras C, Reynaldo G, Rodr\u00edguez-Vera L, Vlaar C, Mejias VL, et al. Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans. Drug Metab Pers Ther. 2020. https:\/\/doi.org\/10.1515\/dmpt-2020-0135.","journal-title":"Drug Metab Pers Ther"},{"issue":"3","key":"4148_CR43","first-page":"253","volume":"15","author":"SW Hill","year":"2009","unstructured":"Hill SW, Varker AS, Karlage K, Myrdal PB. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm. 2009;15(3):253\u201361.","journal-title":"J Manag Care Pharm"},{"issue":"4","key":"4148_CR44","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1021\/acs.jced.8b00977","volume":"64","author":"MV George De La Rosa","year":"2019","unstructured":"George De La Rosa MV, Santiago R, Malav\u00e9 Romero J, Duconge J, Monbaliu JC, L\u00f3pez-Mej\u00edas V, et al. Solubility determination and correlation of warfarin sodium 2-propanol solvate in pure, binary, and ternary solvent mixtures. J Chem Eng Data. 2019;64(4):1399\u2013413.","journal-title":"J Chem Eng Data"},{"key":"4148_CR45","unstructured":"United States Pharmacopeia. Warfarin Sodium Tablets [Internet]. USP-NF. 2022 [cited 2024 Aug 28]. Available from: https:\/\/www.drugs.com\/drug-shortages\/warfarin-sodium-tablets."},{"key":"4148_CR46","unstructured":"Nikon. NIS-Elements BR (Basic Research) User\u2019s Guide (Version. 4.50), Nikon Instruments Inc., 2016."},{"key":"4148_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-1-4615-0215-9_6","volume-title":"Scanning electron microscopy and X-ray microanalysis","author":"JI Goldstein","year":"2003","unstructured":"Goldstein JI, Newbury DE, Echlin P, Joy DC, Lyman CE, Lifshin E, et al. Generation of X-rays in the SEM specimen. In: Scanning electron microscopy and X-ray microanalysis. Boston: Springer; 2003. p. 271\u201396."},{"key":"4148_CR48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/9781119440598","volume-title":"Modern Raman Spectroscopy: A Practical Approach","author":"E Smith","year":"2019","unstructured":"Smith E, Dent G. Modern Raman Spectroscopy: A Practical Approach. Chichester: John Wiley & Sons Ltd; 2019. p. 210."},{"key":"4148_CR49","unstructured":"United States Pharmacopeia. General Chapters, \u2329857\u232a Ultraviolet-Visible Spectroscopy. USP-NF 2020. https:\/\/online.uspnf.com\/uspnf\/document\/1_GUID-4C5C1937-524A-4BED-95E7-384EDE3745E0_4_en-US. Accessed 16 Jan 2025."},{"key":"4148_CR50","unstructured":"United States Pharmacopeia. General Chapter, <711> Dissolution [Internet]. USP-NF. [cited 2025 Apr 25]. Available from: https:\/\/www.usp.org\/harmonization-standards\/pdg\/general-methods\/dissolution."},{"key":"4148_CR51","doi-asserted-by":"crossref","unstructured":"Esbensen KH, Julius LP. Representative Sampling, Data Quality, Validation\u2014A Necessary Trinity in Chemometrics. In: Comprehensive Chemometrics: Chemical and Biochemical Data Analysis. Second edition. Elsevier; 2020. p. 185\u2013203.","DOI":"10.1016\/B978-0-12-409547-2.14872-3"},{"key":"4148_CR52","doi-asserted-by":"crossref","unstructured":"Esbensen KH, Paasch-Mortensen P. Process Sampling: Theory of Sampling - the Missing Link in Process Analytical Technologies (PAT). In: Process Analytical Technology: Spectroscopic Tools and Implementation Strategies for the Chemical and Pharmaceutical Industries: Second edition. 2010. p. 37\u201380.","DOI":"10.1002\/9780470689592.ch3"},{"key":"4148_CR53","unstructured":"Esbensen KH, Swarbrick B. Multivariate Data Analysis. CAMO Software AS; 2018. p. 480."},{"issue":"21","key":"4148_CR54","first-page":"10950","volume":"87","author":"JA Newman","year":"2015","unstructured":"Newman JA, Schmitt PD, Toth SJ, Deng F, Zhang S, Simpson GJ. Analytical Chemistry. Physiol Behav. 2015;87(21):10950\u20135.","journal-title":"Physiol Behav"},{"issue":"12","key":"4148_CR55","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1002\/jps.24657","volume":"104","author":"A Nguyenpho","year":"2015","unstructured":"Nguyenpho A, Ciavarella AB, Siddiqui A, Rahman Z, Akhtar S, Hunt R, et al. Evaluation of in-use stability of anticoagulant drug products: warfarin sodium. J Pharm Sci. 2015;104(12):4232\u201340.","journal-title":"J Pharm Sci"},{"issue":"11","key":"4148_CR56","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/jps.20164","volume":"93","author":"AR Sheth","year":"2004","unstructured":"Sheth AR, Brennessel WW, Young VG, Muller FX, Grant DJW. Solid-state properties of warfarin sodium 2-propanol solvate. J Pharm Sci. 2004;93(11):2669\u201380.","journal-title":"J Pharm Sci"},{"issue":"2","key":"4148_CR57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1107\/S2052520616003954","volume":"72","author":"CR Groom","year":"2016","unstructured":"Groom CR, Bruno IJ, Lightfoot MP, Ward SC. The Cambridge structural database. Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016;72(2):171\u20139.","journal-title":"Acta Crystallogr B Struct Sci Cryst Eng Mater"},{"issue":"5","key":"4148_CR58","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1023\/A:1011979221685","volume":"15","author":"S Taylor Lynne","year":"1998","unstructured":"Taylor Lynne S, Zografi G. The Quantitative Analysis of Crystallinity Using FT-Raman Spectroscopy. Pharm Res. 1998;15(5):755\u201361.","journal-title":"Pharm Res"},{"issue":"5","key":"4148_CR59","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1039\/D4CC05591H","volume":"61","author":"MWS Chong","year":"2024","unstructured":"Chong MWS, Ward MR, McFarlan C, Parrott AJ, Dallin P, Andrews J, et al. Calibration free approaches for rapid polymorph discrimination via low frequency (THz) Raman spectroscopy. Chem Commun. 2024;61(5):925\u20138.","journal-title":"Chem Commun"},{"key":"4148_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020327","author":"S Mohan","year":"2023","unstructured":"Mohan S, Li Y, Chu K, Shi B, De La Paz L, Bakre P, et al. Developing in situ chemometric models with Raman spectroscopy for monitoring an API disproportionation with a complex polymorphic landscape. Pharmaceuticals (Basel). 2023. https:\/\/doi.org\/10.3390\/ph16020327.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"4148_CR61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1211\/jpp.59.2.0005","volume":"59","author":"CJ Strachan","year":"2007","unstructured":"Strachan CJ, Rades T, Gordon KC, Rantanen J. Raman spectroscopy for quantitative analysis of pharmaceutical solids. J Pharm Pharmacol. 2007;59(2):179\u201392.","journal-title":"J Pharm Pharmacol"},{"key":"4148_CR62","volume-title":"Course Notes on the Interpretation of Infrared and","author":"W Mayo Dana","year":"2004","unstructured":"Mayo Dana W, Miller Foil AHRW. Course Notes on the Interpretation of Infrared and. New Jersey: John Wiley & Sons, Inc.; 2004."},{"issue":"1","key":"4148_CR63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1366\/14-07531","volume":"69","author":"Z Hong","year":"2015","unstructured":"Hong Z, Asher SA. Dependence of Raman and resonance Raman intensities on sample self-absorption. Appl Spectrosc. 2015;69(1):75\u201383.","journal-title":"Appl Spectrosc"},{"issue":"11","key":"4148_CR64","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/marc.1994.030151105","volume":"15","author":"L Ping","year":"1994","unstructured":"Ping L, Ding JCR. Suppression of Fluorescence in Raman Spectroscopy of Chromophore-Containing Polymer Samples. Macromol Rapid Commun. 1994;15(11):835\u201340.","journal-title":"Macromol Rapid Commun"},{"issue":"12","key":"4148_CR65","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.optmat.2008.12.030","volume":"31","author":"P Colomban","year":"2009","unstructured":"Colomban P, Slodczyk A. Raman intensity: an important tool to study the structure and phase transitions of amorphous\/crystalline materials. Opt Mater. 2009;31(12):1759\u201363.","journal-title":"Opt Mater"},{"issue":"20","key":"4148_CR66","doi-asserted-by":"publisher","first-page":"14095","DOI":"10.1103\/PhysRevB.61.14095","volume":"61","author":"ACRJ Ferrari","year":"2000","unstructured":"Ferrari ACRJ. Interpretation of Raman spectra of disordered and amorphous carbon. Phys Rev B. 2000;61(20):14095\u2013107.","journal-title":"Phys Rev B"},{"key":"4148_CR67","first-page":"230","volume-title":"Practical Guide to Chemometrics","author":"P Gemberline","year":"1995","unstructured":"Gemberline P. Practical Guide to Chemometrics, vol. 37. Boca Raton: CRC Press; 1995. p. 230."},{"key":"4148_CR68","volume-title":"Multivariate Data Analysis: An introduction to Multivariate Analysis","author":"KHSB Esbensen","year":"2018","unstructured":"Esbensen KHSB. Multivariate Data Analysis: An introduction to Multivariate Analysis. Oslo: Process Analytical Technology and Quality by Design; 2018."},{"issue":"1\u20132","key":"4148_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.07.051","volume":"493","author":"A Siddiqui","year":"2015","unstructured":"Siddiqui A, Rahman Z, Korang-Yeboah M, Khan MA. Development and validation of X-ray diffraction method for quantitative determination of crystallinity in warfarin sodium products. Int J Pharm. 2015;493(1\u20132):1\u20136.","journal-title":"Int J Pharm"},{"key":"4148_CR70","first-page":"419","volume-title":"Pharmaceutical Powder Compaction Technology","author":"G Bolhuis","year":"1996","unstructured":"Bolhuis G, Chowhan Z. Materials for Direct Compaction. In: Alderborn G, Alderborn G, Nystr\u00f6m CNC, editors. Pharmaceutical Powder Compaction Technology. New York: Marcel Dekker, Inc.; 1996. p. 419\u2013500."},{"issue":"14","key":"4148_CR71","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1007\/s10570-021-04093-1","volume":"28","author":"ALP Queiroz","year":"2021","unstructured":"Queiroz ALP, Kerins BM, Yadav J, Farag F, Faisal W, Crowley ME, et al. Investigating microcrystalline cellulose crystallinity using Raman spectroscopy. Cellulose. 2021;28(14):8971\u201385.","journal-title":"Cellulose"},{"issue":"7","key":"4148_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101369","volume":"9","author":"A Al-khattawi","year":"2014","unstructured":"Al-khattawi A, Alyami H, Townsend B, Ma XMA. Evidence-based nanoscopic and molecular framework for excipient functionality in compressed orally disintegrating tablets. PLoS ONE. 2014;9(7):e101369.","journal-title":"PLoS ONE"},{"issue":"53","key":"4148_CR73","doi-asserted-by":"publisher","first-page":"33486","DOI":"10.1039\/C7RA06222B","volume":"7","author":"J Gong","year":"2017","unstructured":"Gong J, Li J, Xu J, Xiang Z, Mo L. Research on cellulose nanocrystals produced from cellulose sources with various polymorphs. RSC Adv. 2017;7(53):33486\u201393.","journal-title":"RSC Adv"},{"issue":"12","key":"4148_CR74","doi-asserted-by":"publisher","first-page":"12476","DOI":"10.1021\/acsomega.5c00044","volume":"10","author":"G Joshi","year":"2025","unstructured":"Joshi G, Rana V, Malik S, Bachheti RK. Assessment of different reaction media for the facile synthesis of cellulose-derived biorenewable polymer cationic cellulose: synthesis, characterization, and perspectives. ACS Omega. 2025;10(12):12476\u201386.","journal-title":"ACS Omega"},{"issue":"11","key":"4148_CR75","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/marc.1994.030151105","volume":"15","author":"P Lu","year":"1994","unstructured":"Lu P, Ding J, Cheng R, Qian R. Suppression of fluorescence in raman spectroscopy of chromophore-containing polymer sample. Macromol Rapid Commun. 1994;15(11):835\u201340.","journal-title":"Macromol Rapid Commun"},{"issue":"5","key":"4148_CR76","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/ceat.200900478","volume":"33","author":"T Stelzer","year":"2010","unstructured":"Stelzer T, Ulrich J. No product design without process design (control)? Chem Eng Technol. 2010;33(5):723\u20139.","journal-title":"Chem Eng Technol"},{"issue":"11","key":"4148_CR77","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1021\/acs.oprd.3c00330","volume":"27","author":"JP Feng","year":"2023","unstructured":"Feng JP, Soto-Bibiloni BAST. Real-Time Monitoring of Crystallization Processes Using a Novel Compact Composite Sensor Arra. Org Process Res Dev. 2023;27(11):2174\u201382.","journal-title":"Org Process Res Dev"},{"key":"4148_CR78","first-page":"1","volume-title":"Encyclopedia of Chemical Technology","author":"J Ulrich","year":"2011","unstructured":"Ulrich J, Stelzer T. Crystallization. In: Heinemann B, editor. Encyclopedia of Chemical Technology. 4th ed. Oxford: John Wiley & Sons Inc; 2011. p. 1\u201363.","edition":"4th ed"},{"issue":"9","key":"4148_CR79","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/pharmaceutics13091364","volume":"13","author":"J Musel\u00edk","year":"2021","unstructured":"Musel\u00edk J, Urbanova M, Barton\u00ed\u010dkov\u00e1 E, Palov\u010d\u00edk J, Vetch\u00fd D, Czernek J, et al. Structural changes of sodium warfarin in tablets affecting the dissolution profiles and potential safety of generic substitution. Pharmaceutics. 2021;13(9):1364.","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"4148_CR80","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijpharm.2003.11.022","volume":"271","author":"IC Sinka","year":"2004","unstructured":"Sinka IC, Burch SF, Tweed JH, Cunningham JC. Measurement of density variations in tablets using X-ray computed tomography. Int J Pharm. 2004;271(1\u20132):215\u201324.","journal-title":"Int J Pharm"},{"key":"4148_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-1923-3","author":"M Alhijjaj","year":"2017","unstructured":"Alhijjaj M, Yassin S, Reading M, Zeitler JA, Belton P, Qi S. Characterization of heterogeneity and spatial distribution of phases in complex solid dispersions by thermal analysis by structural characterization and X-ray micro computed tomography. Pharm Res. 2017. https:\/\/doi.org\/10.1007\/s11095-016-1923-3.","journal-title":"Pharm Res"},{"issue":"5","key":"4148_CR82","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/ph16050733","volume":"16","author":"J Vijayakumar","year":"2023","unstructured":"Vijayakumar J, Goudarzi NM, Eeckaut G, Schrijnemakers K, Cnudde V, Boone MN. Characterization of Pharmaceutical Tablets by X-ray Tomography. Pharmaceuticals. 2023;16(5):733.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"4148_CR83","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ijpharm.2015.03.017","volume":"494","author":"R Daly","year":"2015","unstructured":"Daly R, Harrington TS, Martin GD, Hutchings IM. Inkjet printing for pharmaceutics - a review of research and manufacturing. Int J Pharm. 2015;494(2):554\u201367.","journal-title":"Int J Pharm"},{"key":"4148_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12090853","author":"KS Seo","year":"2020","unstructured":"Seo KS, Bajracharya R, Lee SH, Han HK. Pharmaceutical application of tablet film coating. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12090853.","journal-title":"Pharmaceutics"},{"key":"4148_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122456","author":"R Dong","year":"2023","unstructured":"Dong R, Nassar M, Friend B, Teckoe J, Zeitler JA. Studying the dissolution of immediate release film coating using terahertz pulsed imaging. Int J Pharm. 2023. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122456.","journal-title":"Int J Pharm"},{"key":"4148_CR86","doi-asserted-by":"publisher","DOI":"10.1208\/pt0803057","author":"S Bose","year":"2007","unstructured":"Bose S, Bogner RH. Solventless photocurable film coating: evaluation of drug release, mechanical strength, and photostability. AAPS PharmSciTech. 2007. https:\/\/doi.org\/10.1208\/pt0803057.","journal-title":"AAPS PharmSciTech"},{"key":"4148_CR87","unstructured":"N\u00e6s T, Isaksson T, Fearn T, Davies T. A User-Friendly Guide to Multivariate Calibration and Classification. First edition, Chichester: NIR Publications; 2002."},{"key":"4148_CR88","first-page":"53","volume-title":"Multivariate Analysis in the Pharmaceutical Industry","author":"KH Esbensen","year":"2018","unstructured":"Esbensen KH, Romanach RJ, Roman-Ospino AD. Theory of Sampling ( TOS ): A Necessary and Sufficient Guarantee for Reliable Multivariate Data Analysis in Pharmaceutical. In: Multivariate Analysis in the Pharmaceutical Industry. Academic Press; 2018. p. 53\u201391."},{"key":"4148_CR89","unstructured":"FDA. Development and Submission of Near Infrared Analytical Procedures Guidance for Industry [Internet]. Food and Drug Administration. 2015 [cited 2026 Jan 21]. p. 24. Available from: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm."},{"key":"4148_CR90","unstructured":"FDA. Guidance for Industry, PAT-A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance [Internet]. 2004 [cited 2026 Feb 25]. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm070305."},{"key":"4148_CR91","unstructured":"ICH. Validation of Analytical Procedures: Test and Methodology Q2 (R1) [Internet]. Vol. 1994. 2013. p. 447\u201360. Available from: https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29Guideline. Accessed: 06-03-3025."},{"key":"4148_CR92","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1039\/C4AN01798F","volume":"140","author":"JA Gri","year":"2015","unstructured":"Gri JA, Owen W, Matousek P. Development of Transmission Raman Spectroscopy towards the in line, high throughput and non- destructive quantitative analysis of pharmaceutical solid oral dose. Analyst. 2015;140:107\u201312.","journal-title":"Analyst"},{"issue":"5","key":"4148_CR93","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1021\/acs.oprd.3c00338","volume":"28","author":"DV Silva-brenes","year":"2024","unstructured":"Silva-brenes DV, Reyes-vargas SK, Duconge J, Vlaar C, Stelzer T, Monbaliu JCM. Continuous flow intensification for the synthesis of high-purity warfarin. Org Process Res Dev. 2024;28(5):1704\u201312.","journal-title":"Org Process Res Dev"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04148-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04148-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04148-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:02:16Z","timestamp":1788544936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04148-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":93,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4148"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04148-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}